Is low molecular weight heparin a neuroprotectant?

被引：42
作者：
Jonas, S [1 ]
Sugimori, M [1 ]
Llinas, R [1 ]
机构：
[1] NYU, SCH MED, DEPT PHYSIOL & NEUROSCI, NEW YORK, NY 10016 USA
来源：
NEUROPROTECTIVE AGENTS - THIRD INTERNATIONAL CONFERENCE | 1997年 / 825卷
关键词：
D O I：
10.1111/j.1749-6632.1997.tb48449.x
中图分类号：
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号：
07 ; 0710 ; 09 ;
摘要：
引用
收藏
页码：389 / 393
页数：5
相关论文
共 8 条
  • [1] BLACK SC, 1995, CARDIOVASC RES, V29, P629, DOI 10.1016/0008-6363(96)88632-9
  • [2] INTRAVENOUS HEPARIN FOR THE PREVENTION OF STROKE PROGRESSION IN ACUTE PARTIAL STABLE STROKE - A RANDOMIZED CONTROLLED TRIAL
    DUKE, RJ
    BLOCH, RF
    TURPIE, AGG
    TREBILCOCK, R
    BAYER, N
    [J]. ANNALS OF INTERNAL MEDICINE, 1986, 105 (06) : 825 - 828
  • [3] EFFECTS OF HEPARIN AND N-ACETYL HEPARIN ON ISCHEMIA/REPERFUSION-INDUCED ALTERATIONS IN MYOCARDIAL-FUNCTION IN THE RABBIT ISOLATED HEART
    FRIEDRICHS, GS
    KILGORE, KS
    MANLEY, PJ
    GRALINSKI, MR
    LUCCHESI, BR
    [J]. CIRCULATION RESEARCH, 1994, 75 (04) : 701 - 710
  • [4] LOW-MOLECULAR-WEIGHT HEPARIN FOR THE TREATMENT OF ACUTE ISCHEMIC STROKE
    KAY, R
    WONG, KS
    YU, YL
    CHAN, YW
    TSOI, TH
    AHUJA, AT
    CHAN, FL
    FONG, KY
    LAW, CB
    WONG, A
    WOO, J
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (24) : 1588 - 1593
  • [5] DEFINED GLYCOSAMINOGLYCAN MOTIFS HAVE OPPOSITE EFFECTS ON NEURONAL POLARITY IN-VITRO
    LAFONT, F
    PROCHIANTZ, A
    VALENZA, C
    PETITOU, M
    PASCAL, M
    ROUGET, M
    ROUSSELET, A
    [J]. DEVELOPMENTAL BIOLOGY, 1994, 165 (02) : 453 - 468
  • [6] CAN SIMPLE QUESTIONS ASSESS OUTCOME AFTER STROKE
    LINDLEY, RI
    WADDELL, F
    LIVINGSTONE, M
    SANDERCOCK, P
    DENNIS, MS
    SLATTERY, J
    SMITH, B
    WARLOW, C
    [J]. CEREBROVASCULAR DISEASES, 1994, 4 (04) : 314 - 324
  • [7] LLINAS R, 1990, FID RES FDN, V4, P1
  • [8] Sugimori M., 1995, Society for Neuroscience Abstracts, V21, P2019
1